These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9870405)
1. Determination of titanocene, a new drug with anticancer potential, and its metabolism in solution by capillary electrophoresis. Wittrisch H; Schröer HP; Vogt J; Vogt C Electrophoresis; 1998 Nov; 19(16-17):3012-7. PubMed ID: 9870405 [TBL] [Abstract][Full Text] [Related]
2. Binding and hydrolysis studies of antitumoural titanocene dichloride and Titanocene Y with phosphate diesters. Erxleben A; Claffey J; Tacke M J Inorg Biochem; 2010 Apr; 104(4):390-6. PubMed ID: 20036426 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma. Köpf-Maier P Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588 [TBL] [Abstract][Full Text] [Related]
4. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride. Waern JB; Dillon CT; Harding MM J Med Chem; 2005 Mar; 48(6):2093-9. PubMed ID: 15771451 [TBL] [Abstract][Full Text] [Related]
5. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour. Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106 [TBL] [Abstract][Full Text] [Related]
6. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes. Pérez-Quintanilla D; Gómez-Ruiz S; Zizak Z; Sierra I; Prashar S; del Hierro I; Fajardo M; Juranić ZD; Kaluderović GN Chemistry; 2009; 15(22):5588-97. PubMed ID: 19370742 [TBL] [Abstract][Full Text] [Related]
7. Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride. Guo M; Guo Z; Sadler PJ J Biol Inorg Chem; 2001 Sep; 6(7):698-707. PubMed ID: 11681703 [TBL] [Abstract][Full Text] [Related]
8. [Determination of organometallic antitumor crude drug titanocene dichloride by NP-HPLC]. Li Y; Ning M; Li Q Se Pu; 2007 Mar; 25(2):282-3. PubMed ID: 17580706 [No Abstract] [Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of Titanocene Dichloride (CAS No. 1271-19-8) in F344/N Rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1991 Sep; 399():1-182. PubMed ID: 12637960 [TBL] [Abstract][Full Text] [Related]
10. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells. O'Connor K; Gill C; Tacke M; Rehmann FJ; Strohfeldt K; Sweeney N; Fitzpatrick JM; Watson RW Apoptosis; 2006 Jul; 11(7):1205-14. PubMed ID: 16699961 [TBL] [Abstract][Full Text] [Related]
11. Antiproliferative activity of Titanocene Y against tumor colony-forming units. Oberschmidt O; Hanauske AR; Pampillón C; Sweeney NJ; Strohfeldt K; Tacke M Anticancer Drugs; 2007 Mar; 18(3):317-21. PubMed ID: 17264765 [TBL] [Abstract][Full Text] [Related]
12. Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives. Abeysinghe PM; Harding MM Dalton Trans; 2007 Aug; (32):3474-82. PubMed ID: 17680034 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice. Beckhove P; Oberschmidt O; Hanauske AR; Pampillón C; Schirrmacher V; Sweeney NJ; Strohfeldt K; Tacke M Anticancer Drugs; 2007 Mar; 18(3):311-5. PubMed ID: 17264764 [TBL] [Abstract][Full Text] [Related]
14. A controlled release system of titanocene dichloride by electrospun fiber and its antitumor activity in vitro. Chen P; Wu QS; Ding YP; Chu M; Huang ZM; Hu W Eur J Pharm Biopharm; 2010 Nov; 76(3):413-20. PubMed ID: 20854905 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents. Peri D; Meker S; Shavit M; Tshuva EY Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656 [TBL] [Abstract][Full Text] [Related]
16. CZE-ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP. Groessl M; Hartinger CG; Dyson PJ; Keppler BK J Inorg Biochem; 2008; 102(5-6):1060-5. PubMed ID: 18222004 [TBL] [Abstract][Full Text] [Related]
17. A simple capillary electrophoresis with electrochemical detection method for determination of the hydrolysis rate constant of chlorogenic acid. Tong P; Zhang L; He Y; Chi Y; Chen G Talanta; 2009 Mar; 77(5):1790-4. PubMed ID: 19159800 [TBL] [Abstract][Full Text] [Related]
18. Capillary electrophoresis of chitooligosaccharides in acidic solution: simple determination using a quaternary-ammonium-modified column and indirect photometric detection with crystal violet. Hattori T; Anraku N; Kato R J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):477-80. PubMed ID: 20004627 [TBL] [Abstract][Full Text] [Related]
19. Analyses of Titanocenes in the spheroid-based cellular angiogenesis assay. Weber H; Claffey J; Hogan M; Pampillón C; Tacke M Toxicol In Vitro; 2008 Mar; 22(2):531-4. PubMed ID: 17981007 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of anticancer titanocene derivatives: an insight from quantum chemical calculations. Sponer JE; Leszczynski J; Sponer J J Phys Chem B; 2006 Oct; 110(39):19632-6. PubMed ID: 17004831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]